Cargando…
Association of the Serum Vascular Endothelial Growth Factor Levels With Benign Prostate Hyperplasia and Prostate Malignancies
BACKGROUND: Recently, the development of new biomarkers as prognostic and predictive markers in prostate cancer has been crucial. OBJECTIVES: This study was aimed to determine whether serum vascular endothelial growth factor (VEGF) levels would be a prognostic marker or risk assessment factor in pat...
Autores principales: | Sharif, Mohammad Reza, Shaabani, Amirreza, Mahmoudi, Hossein, Nikoueinejad, Hassan, Akbari, Hossein, Einollahi, Behzad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090676/ https://www.ncbi.nlm.nih.gov/pubmed/25032132 http://dx.doi.org/10.5812/numonthly.14778 |
Ejemplares similares
-
Benign Prostatic Hyperplasia
Publicado: (2015) -
Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015) -
Serum omentin-1 level in patients with benign prostatic hyperplasia
por: He, Haiqing, et al.
Publicado: (2020) -
Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia
por: Abotsi, Ebenezer, et al.
Publicado: (2022) -
Numerical status of CD4(+)CD25(+)FoxP3(+) and CD8(+)CD28(-) regulatory T cells in multiple sclerosis
por: Kouchaki, Ebrahim, et al.
Publicado: (2014)